Comparison of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks With Sofosbuvir and Ribavirin for 12 Weeks in Adults With Chronic Genotype 2 HCV Infection

NCT02220998 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

269

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C Virus Infection

Interventions

DRUG: SOF/VEL
DRUG: SOF
DRUG: RBV

Sponsor

Gilead Sciences